Canopy Growth Corporation (WEED.TO)
CAD 2.0
(21.21%)
CAD 2.0
(21.21%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 683.17 Million CAD | -47.73% |
| 2022 | 1.3 Billion CAD | -12.93% |
| 2021 | 1.5 Billion CAD | -5.18% |
| 2020 | 1.58 Billion CAD | 152.94% |
| 2019 | 625.81 Million CAD | -33.84% |
| 2018 | 945.97 Million CAD | 11132.19% |
| 2017 | 8.42 Million CAD | -18.47% |
| 2016 | 10.33 Million CAD | 156.84% |
| 2015 | 4.02 Million CAD | 114.51% |
| 2014 | 1.87 Million CAD | 4539.14% |
| 2013 | 40.41 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 623.53 Million CAD | -8.73% |
| 2023 Q3 | 693.27 Million CAD | -9.4% |
| 2023 Q4 | 683.17 Million CAD | -1.46% |
| 2023 FY | 683.17 Million CAD | -47.73% |
| 2023 Q1 | 1.13 Billion CAD | -13.16% |
| 2023 Q2 | 765.16 Million CAD | -32.58% |
| 2022 Q1 | 1.45 Billion CAD | -2.88% |
| 2022 Q2 | 1.35 Billion CAD | -7.11% |
| 2022 Q3 | 1.2 Billion CAD | -10.97% |
| 2022 FY | 1.3 Billion CAD | -12.93% |
| 2022 Q4 | 1.3 Billion CAD | 8.4% |
| 2021 Q3 | 1.65 Billion CAD | 8.3% |
| 2021 FY | 1.5 Billion CAD | -5.18% |
| 2021 Q4 | 1.5 Billion CAD | -9.22% |
| 2021 Q2 | 1.52 Billion CAD | -9.71% |
| 2021 Q1 | 1.69 Billion CAD | 6.81% |
| 2020 Q1 | 635.72 Million CAD | 1.58% |
| 2020 Q2 | 533.69 Million CAD | -16.05% |
| 2020 Q3 | 769.63 Million CAD | 44.21% |
| 2020 FY | 1.58 Billion CAD | 152.94% |
| 2020 Q4 | 1.58 Billion CAD | 105.68% |
| 2019 Q2 | 604.48 Million CAD | -24.98% |
| 2019 Q4 | 625.81 Million CAD | 12.2% |
| 2019 Q3 | 557.75 Million CAD | -7.73% |
| 2019 Q1 | 805.79 Million CAD | -14.82% |
| 2019 FY | 625.81 Million CAD | -33.84% |
| 2018 Q2 | 910.16 Million CAD | 46.73% |
| 2018 FY | 945.97 Million CAD | 11132.19% |
| 2018 Q4 | 945.97 Million CAD | 19.52% |
| 2018 Q3 | 791.49 Million CAD | -13.04% |
| 2018 Q1 | 620.28 Million CAD | 7265.09% |
| 2017 FY | 8.42 Million CAD | -18.47% |
| 2017 Q4 | 8.42 Million CAD | -4.22% |
| 2017 Q3 | 8.79 Million CAD | -8.18% |
| 2017 Q2 | 9.57 Million CAD | -3.41% |
| 2017 Q1 | 9.91 Million CAD | -4.03% |
| 2016 Q3 | 7.17 Million CAD | -3.65% |
| 2016 FY | 10.33 Million CAD | 156.84% |
| 2016 Q2 | 7.44 Million CAD | 80.28% |
| 2016 Q4 | 10.33 Million CAD | 44.07% |
| 2016 Q1 | 4.12 Million CAD | 2.64% |
| 2015 Q3 | 3.97 Million CAD | -32.63% |
| 2015 Q4 | 4.02 Million CAD | 1.21% |
| 2015 FY | 4.02 Million CAD | 114.51% |
| 2015 Q1 | 1.89 Million CAD | -1.3% |
| 2015 Q2 | 5.89 Million CAD | 211.96% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q4 | 1.91 Million CAD | 2.19% |
| 2014 Q3 | 1.87 Million CAD | 0.0% |
| 2014 Q1 | - CAD | -100.0% |
| 2014 FY | 1.87 Million CAD | 4539.14% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | 40.41 Thousand CAD | 0.0% |
| 2013 Q4 | 39.73 Thousand CAD | -1.68% |
| 2013 FY | 40.41 Thousand CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | -551.938% |
| Avicanna Inc. | 1.8 Million CAD | -37782.507% |
| Avant Brands Inc. | 18.7 Million CAD | -3552.936% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -430836.341% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | -54379.426% |
| Knight Therapeutics Inc. | 69.09 Million CAD | -888.8% |
| MediPharm Labs Corp. | 2.29 Million CAD | -29667.843% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -440656.129% |
| Willow Biosciences Inc. | 2.15 Million CAD | -31587.013% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | -329.546% |